Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway.
about
Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.Atorvastatin inhibits cholesterol-induced caspase-3 cleavage through down-regulation of p38 and up-regulation of Bcl-2 in the rat carotid artery.The effect and mechanism of dopamine D1 receptors on the proliferation of osteosarcoma cells.
P2860
Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Atorvastatin suppresses oxidiz ...... lated by the p38 MAPK pathway.
@en
Atorvastatin suppresses oxidiz ...... lated by the p38 MAPK pathway.
@nl
type
label
Atorvastatin suppresses oxidiz ...... lated by the p38 MAPK pathway.
@en
Atorvastatin suppresses oxidiz ...... lated by the p38 MAPK pathway.
@nl
prefLabel
Atorvastatin suppresses oxidiz ...... lated by the p38 MAPK pathway.
@en
Atorvastatin suppresses oxidiz ...... lated by the p38 MAPK pathway.
@nl
P2093
P2860
P1476
Atorvastatin suppresses oxidiz ...... lated by the p38 MAPK pathway.
@en
P2093
Dan-Dan Li
Ling-Hong Shen
Liu-Hua Hu
Shu-Xuan Jin
P2860
P2888
P304
P356
10.1007/S11010-012-1427-3
P577
2012-08-14T00:00:00Z